NOVABAY PHARMACEUTICALS INC (NBY) Stock News

NYSEARCA:NBY - NYSE Arca - US66987P4090 - Common Stock - Currency: USD

0.65 +0 (+0.65%)

Premarket: 0.683 +0.03 (+5.08%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NBY Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Zacks Investment Research - Mentions: BKD

Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates

4 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

5 months ago - By: Benzinga - Mentions: AZTR OGEN XNCR EYPT ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

a year ago - By: Benzinga

Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%

6 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

7 months ago - By: NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

7 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

8 months ago - By: NovaBay Pharmaceuticals

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

8 months ago - By: NovaBay Pharmaceuticals, Inc.

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand

8 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

8 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

9 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

10 months ago - By: Halper Sadeh LLC

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders

10 months ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

a year ago - By: InvestorPlace

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

a year ago - By: InvestorPlace - Mentions: WINT BFI CREV EVRI ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

a year ago - By: NovaBay Pharmaceuticals, Inc. - Mentions: EYEN

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

a year ago - By: InvestorPlace - Mentions: GDHG WLGS MICS CTM ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

a year ago - By: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American